- Home
- REKR vs HURA Comparison
REKR vs HURA Comparison
Compare REKR & HURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | REKR | HURA |
|---|---|---|
| Founded | 2017 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | |
| Sector | Telecommunications | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 151.6M | 131.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | REKR | HURA |
|---|---|---|
| Price | $1.55 | $0.73 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | ★ 2.8M | 662.7K |
| Earning Date | 11-13-2025 | 02-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $49,028,000.00 | N/A |
| Revenue This Year | $11.82 | N/A |
| Revenue Next Year | $22.78 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 11.89 | N/A |
| 52 Week Low | $0.62 | $0.70 |
| 52 Week High | $3.42 | $5.50 |
Technical Indicators
Market Signals| Indicator | REKR | HURA |
|---|---|---|
| Relative Strength Index (RSI) | 42.98 | 25.27 |
| Support Level | $1.37 | $0.72 |
| Resistance Level | $1.65 | $0.80 |
| Average True Range (ATR) | 0.09 | 0.09 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 54.41 | 6.93 |
Price Performance
Historical ComparisonAbout REKR Rekor Systems Inc.
Rekor Systems Inc is a United States-based company. The company is engaged in providing real-time roadway intelligence through AI-driven decisions. The firm uses artificial intelligence to analyze video streams and transform them into AI-driven decisions. The company's technology and machine learning models power all solutions, including Rekor Command for transportation management, Rekor Discover for urban mobility, and Rekor Scout for public safety, and commercial use. Its geographical segments are the United States and Others, of which a majority of its revenue comes from the United States.
About HURA TuHURA Biosciences Inc.
TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.